Showing 3421-3430 of 4164 results for "".
- CorneaGen Raises $37 Million to Advance Development of Cornea Cell Therapyhttps://modernod.com/news/corneagen-raises-37-million-to-advance-development-of-cornea-cell-therapy/2476950/CorneaGen announced the closing of a $37 million Series B financing. The round was led by Flying L Partners in collaboration with Falcon Vision, a platform formed by KKR to advance innovation in ophthalmology. Petrichor Healthcare Capital Management also participated in the equity round and provi
- CorneaGen Raises $37 Million to Advance Development of Cornea Cell Therapyhttps://modernod.com/news/corneagen-raises-37-million-to-advance-development-of-cornea-cell-therapy/2476948/CorneaGen announced the closing of a $37 million Series B financing. The round was led by Flying L Partners in collaboration with Falcon Vision, a platform formed by KKR to advance innovation in ophthalmology. Petrichor Healthcare Capital Management also participated significantly in the equity r
- Fight For Sight and Prevent Blindness Announce Call for Entries for the 2020 Joanne Angle Public Health Awardhttps://modernod.com/news/fight-for-sight-and-prevent-blindness-announce-call-for-entries-for-the-2020-joanne-angle-public-health-award/2476933/National non-profit organizations Fight for Sight and Prevent Blindness are announcing a call for applications for the Joanne Angle Public Health Award, a $25,000 grant to support a public health research project seeking to put an end to unnecessary vision loss. The award was named for Ms
- RightEye Releases Fully Commercialized Version of EyeQ Trainer Oculomotor Exercise Programhttps://modernod.com/news/righteye-releases-fully-commercialized-version-of-eyeq-trainer-oculomotor-exercise-program/2476892/RightEye has released its fully commercialized version of EyeQ Trainer, an oculomotor exercise program. Paired with its suite of EyeQ Tests, RightEye now offers a complete solution for addressing functional vision impairments faced by millions of Americans. The product will showcase at Vis
- Alcon Launches New Planning Software and Patient Interface for the WaveLight Refractive Suitehttps://modernod.com/news/alcon-launches-new-planning-software-and-patient-interface-for-the-wavelight-refractive-suite/2476863/Alcon recently launched two additions to its WaveLight Refractive Suite to further support LASIK surgery performance and results. The Phorcides Analytic Engine diagnostic software, designed to help analyze and confirm the topographic treatment for an eye in Contoura Vision, allows surgeons to cal
- ProQR Receives Fast Track Designation from FDA for QR-1123 for Autosomal Dominant Retinitis Pigmentosahttps://modernod.com/news/proqr-receives-fast-track-designation-from-fda-for-qr-1123-for-autosomal-dominant-retinitis-pigmentosa/2479540/ProQR Therapeutics announced that it received fast track designation from the FDA for QR-1123, a first-in-class investigational antisense oligonucleotide designed to address the underlying cause of vision loss associated with autosomal dominant retinitis pigmentosa (adRP) due to the P23H mutation
- NHS England to Fund Novartis’ Gene Therapy Luxturna for Inherited Retinal Diseasehttps://modernod.com/news/nhs-england-to-fund-novartis-gene-therapy-luxturna-for-inherited-retinal-disease/2476855/NHS England announced Wednesday funding for Novartis’ Luxturna (voretigene neparvovec) after agreeing a deal with the company that will provide access to the gene therapy from January 2020. The one-time treatment gained European Commission approval last year for patients with vision loss du
- New Accessible Products Hotline to Offer Advice on Products for Blind or Visually Impairedhttps://modernod.com/news/new-accessible-products-hotline-to-offer-advice-on-products-for-blind-or-visually-impaired/2476823/Envision has launched a first-of-its-kind Accessible Products Hotline that aims to help consumers with vision loss find products that fit their unique accessibility needs. Funded by a grant from the Consumer Technology Association (CTA) Foundation, the hotline will be operated by the William L. H
- FDA Approves New Paragon Contact Lens Manufacturing Facility in Phoenixhttps://modernod.com/news/fda-approves-new-paragon-contact-lens-manufacturing-facility-in-phoenix/2476817/The FDA has approved Paragon Vision Science’s newly-constructed contact lens manufacturing site in suburban Phoenix, paving the way for the company’s ongoing domestic and global expansion. The Gilbert, Ariziona facility will produce advanced ortho-k products such as Paragon CRT for use in
- Bascom Palmer Eye Institute Ranked Nation’s No. 1 in Ophthalmologyhttps://modernod.com/news/bascom-palmer-eye-institute-ranked-nations-no-1-in-ophthalmology/2476783/U.S News & World Report has once again ranked Bascom Palmer Eye Institute of the University of Miami Health System as the nation’s best in ophthalmology. Recognized as a global leader in vision research, medical education, and patient care, this year marks the 18th time that Bascom P